NHS Hospitals Can Reject Palantir, but Patients Have No Choice

The UK health service is outsourcing patient data to Palantir Technologies without individual consent mechanisms, creating a structural power imbalance where institutional procurement decisions override personal data preferences. This establishes a precedent where algorithmic infrastructure vendors gain access to sensitive health records at scale, with hospital-level opt-out as the only friction point—a choice most patients won't know exists or understand. Parliament reviews the contract renewal in February 2027. The open question: whether the NHS retains the technical and legal autonomy to make this decision independently when the renewal arrives.